US Stock MarketDetailed Quotes

SLN Silence Therapeutics

Watchlist
  • 4.480
  • +0.160+3.70%
Close Mar 4 16:00 ET
  • 4.460
  • -0.020-0.45%
Post 19:09 ET
211.57MMarket Cap-3.54P/E (TTM)

Silence Therapeutics Key Stats

Silence Therapeutics Q4 2024 Earnings Date

Currency:USDFeb 27, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
4.69M
24.33M
+19.64M
Beat Est.
+75.34%
+519.60%
+419.20%
EPS
-0.16
0.31
+0.47
Beat Est.
+66.60%
+158.95%
+291.69%
Buy

Mar 4, 2025

Silence Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: GBP

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 3.321M--
--2025/Q1-- / 3.332M--
Feb 27, 20252024/Q4-- / 3.733M--
--2024/Q31.142M / 3.000M--
--2024/Q2598.000K / 9.850M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 3.321M--
--2025/Q1-- / 3.332M--
Feb 27, 20252024/Q4-- / 3.733M--
--2024/Q31.142M / 3.000M--
--2024/Q2598.000K / 9.850M--

Unlock Free Earnings Estimates

Silence Therapeutics Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Mar 4, 2025

Buy

  • Buy

    85.71%
  • Hold

    0.00%
  • Sell

    14.29%

Price Target

No Data